JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Sees Significant Decline in Short Interest

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) was the recipient of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 168,500 shares, a decline of 44.8% from the February 28th total of 305,100 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ? days.

JCR Pharmaceuticals Stock Performance

Shares of JCR Pharmaceuticals stock remained flat at $4.57 during midday trading on Friday. JCR Pharmaceuticals has a 12 month low of $4.30 and a 12 month high of $4.70. The company’s 50 day moving average is $4.57 and its 200 day moving average is $4.58.

JCR Pharmaceuticals Company Profile

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.